Eli Lilly and Company (LLY) Insider Trading
- $379,508,176.85
- $26,381,893,432.85
- Nov. 8, 2024
- Lilly Endowment Inc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 4, 2017 | SVP | 25,000 | $82.76 | Sell | $2,069,000.00 | |
| March 30, 2017 | Major Shareholder | 210,000 | $84.67 | Sell | $17,780,700.00 | |
| Feb. 17, 2017 | Major Shareholder | 230,000 | $80.27 | Sell | $18,462,100.00 | |
| Feb. 6, 2017 | SVP | 15,000 | $77.66 | Sell | $1,164,900.00 | |
| Feb. 3, 2017 | EVP | 11,162 | $77.14 | Sell | $861,036.68 | |
| Feb. 2, 2017 | Insider | 2,000 | $77.52 | Sell | $155,040.00 | |
| Feb. 1, 2017 | Major Shareholder | 220,000 | $77.35 | Sell | $17,017,000.00 | |
| Dec. 16, 2016 | Director | 500 | $71.85 | Buy | $35,925.00 | |
| Dec. 16, 2016 | Major Shareholder | 200,000 | $72.59 | Sell | $14,518,000.00 | |
| Dec. 16, 2016 | Insider | 2,093 | $82.23 | Sell | $172,107.39 | |
| Dec. 16, 2016 | SVP | 20,242 | $72.65 | Sell | $1,470,581.30 | |
| Oct. 5, 2016 | Insider | 2,248 | $81.37 | Sell | $182,919.76 | |
| Aug. 15, 2016 | Director | 5,773 | $80.43 | Buy | $464,322.39 | |
| Aug. 12, 2016 | Director | 2,560 | $80.42 | Buy | $205,875.20 | |
| July 29, 2016 | Major Shareholder | 205,000 | $82.94 | Sell | $17,002,700.00 | |
| July 28, 2016 | Major Shareholder | 240,000 | $82.87 | Sell | $19,888,800.00 | |
| July 28, 2016 | Insider | 1,213 | $83.16 | Sell | $100,873.08 | |
| July 12, 2016 | Major Shareholder | 210,000 | $79.54 | Sell | $16,703,400.00 | |
| July 7, 2016 | Major Shareholder | 225,000 | $79.14 | Sell | $17,806,500.00 | |
| June 30, 2016 | Major Shareholder | 215,000 | $78.46 | Sell | $16,868,900.00 | |
| June 29, 2016 | Major Shareholder | 220,000 | $77.86 | Sell | $17,129,200.00 | |
| June 10, 2016 | SVP | 992 | $73.77 | Sell | $73,179.84 | |
| May 31, 2016 | Major Shareholder | 200,000 | $75.12 | Sell | $15,024,000.00 | |
| May 12, 2016 | Major Shareholder | 190,000 | $75.86 | Sell | $14,413,400.00 | |
| May 12, 2016 | Director | 1,080 | $75.75 | Buy | $81,810.00 | |
| May 2, 2016 | CAO | 1,600 | $75.86 | Sell | $121,376.00 | |
| April 29, 2016 | Major Shareholder | 180,000 | $75.44 | Sell | $13,579,200.00 | |
| April 27, 2016 | SVP | 12,000 | $76.27 | Sell | $915,240.00 | |
| April 8, 2016 | Major Shareholder | 200,000 | $74.29 | Sell | $14,858,000.00 | |
| Feb. 5, 2016 | SVP | 15,230 | $78.87 | Sell | $1,201,190.10 | |
| Feb. 3, 2016 | CFO | 10,483 | $77.78 | Sell | $815,367.74 | |
| Feb. 3, 2016 | SVP | 5,733 | $77.66 | Sell | $445,224.78 | |
| Feb. 1, 2016 | Director | 3,170 | $78.62 | Buy | $249,225.40 | |
| Jan. 29, 2016 | SVP | 5,000 | $78.75 | Sell | $393,750.00 | |
| Dec. 21, 2015 | Major Shareholder | 205,000 | $86.00 | Sell | $17,630,000.00 | |
| Dec. 15, 2015 | Major Shareholder | 215,000 | $85.60 | Sell | $18,404,000.00 | |
| Dec. 9, 2015 | VP | 25,000 | $83.88 | Sell | $2,097,000.00 | |
| Dec. 2, 2015 | major shareholder | 210,000 | $85.09 | Sell | $17,868,900.00 | |
| Nov. 20, 2015 | major shareholder | 205,000 | $84.54 | Sell | $17,330,700.00 | |
| Oct. 29, 2015 | major shareholder | 200,000 | $82.28 | Sell | $16,456,000.00 | |
| Oct. 9, 2015 | major shareholder | 215,000 | $85.86 | Sell | $18,459,900.00 | |
| Oct. 5, 2015 | major shareholder | 260,000 | $86.46 | Sell | $22,479,600.00 | |
| Sept. 18, 2015 | major shareholder | 250,000 | $89.04 | Sell | $22,260,000.00 | |
| June 10, 2015 | Major Shareholder | 210,000 | $82.39 | Sell | $17,301,900.00 | |
| June 4, 2015 | Major Shareholder | 200,000 | $77.90 | Sell | $15,580,000.00 | |
| May 29, 2015 | SVP | 20,000 | $78.08 | Sell | $1,561,600.00 | |
| May 20, 2015 | Major Shareholder | 190,000 | $73.43 | Sell | $13,951,700.00 | |
| May 15, 2015 | Major Shareholder | 200,000 | $72.83 | Sell | $14,566,000.00 | |
| May 8, 2015 | Major Shareholder | 195,000 | $73.28 | Sell | $14,289,600.00 | |
| May 1, 2015 | Major Shareholder | 200,000 | $73.09 | Sell | $14,618,000.00 |
Insiders are both buying and selling Eli Lilly and Company stock.
The insider traders at Eli Lilly and Company are: Lilly Endowment Inc, Donald A Zakrowski, Alfonso G Zulueta, Enrique A Conterno, Jackson P Tai, Susan Mahony, Eli & Co Lilly, Stephen F Fry, Jeffrey N Simmons, Melissa S Barnes, Joshua L Smiley, David A Ricks, Myles O'neill, Anne E White, Derica W Rice, Alonzo Weems, Aarti S Shah, Christi Shaw, Fionnuala M Walsh, Jan M Lundberg, Johna Norton, Maria A Crowe, Michael J Harrington, Ilya Yuffa, Acquisition Corp Kearny, LILLY ENDOWMENT INC, David A. Ricks, Marschall S Runge, Enrique Conterno, Daniel Skovronsky, Derica W. Rice, Jacques Tapiero, Patrik Jonsson, Jackson Tai, and R David Hoover
The most active insider trader at Eli Lilly and Company is Lilly Endowment Inc with 226 trades.
Lilly Endowment Inc has sold the most Eli Lilly and Company stock with a total value of $26,469,075,393.70.
Acquisition Corp Kearny has bought the most Eli Lilly and Company stock with a total value of $749,816,700.00.
The most recent insider trade for Eli Lilly and Company was on Nov. 8, 2024.
The single biggest insider buy for Eli Lilly and Company was from Acquisition Corp Kearny with a total value of $374,908,350.00 on Nov. 30, 2022.
The single biggest insider sell for Eli Lilly and Company was from Lilly Endowment Inc with a total value of $20,590,670,905.00 on Aug. 28, 2023.